Cassava Sciences Inc (SAVA) - Financial and Strategic SWOT Analysis Review

Cassava Sciences Inc (SAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cassava Sciences Inc (Cassava Sciences), formerly known as Pain Therapeutics Inc is a clinical-stage biopharmaceutical company that develops drugs for the treatment of severe pain and neurodegenerative diseases, with a special focus on Alzheimers disease. The companys lead product candidate PTI-125 is a small molecule being developed for the treatment of Alzheimers disease. It is in Phase II clinical trial in patients with Alzheimers disease. The company is also developing PTI-125Dx, a blood-based biomarker/diagnostic for the detection of Alzheimers disease; Fenrock, a proprietary abuse-deterrent transdermal pain patch for treating severe pain. Cassava Sciences is headquartered in Austin, Texas, the US.

Cassava Sciences Inc Key Recent Developments

Nov 09,2020: Cassava Sciences reports third quarter 2020 financial results
Aug 12,2020: Cassava Sciences announces second quarter 2020 financial results and mid-year business review
Jun 18,2020: Cassava Sciences: Departure of board of directors
May 06,2020: Cassava Sciences reports first quarter 2020 financial results and provides business update
Mar 26,2020: Cassava Sciences announces full-year 2019 financial results and anticipated key milestones for 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Section 1 - About the Company
Cassava Sciences Inc - Key Facts
Cassava Sciences Inc - Key Employees
Cassava Sciences Inc - Key Employee Biographies
Cassava Sciences Inc - Major Products and Services
Cassava Sciences Inc - History
Cassava Sciences Inc - Company Statement
Cassava Sciences Inc - Locations And Subsidiaries
Head Office
Section 2 Company Analysis
Company Overview
Cassava Sciences Inc - Business Description
Cassava Sciences Inc - SWOT Analysis
SWOT Analysis - Overview
Cassava Sciences Inc - Strengths
Cassava Sciences Inc - Weaknesses
Cassava Sciences Inc - Opportunities
Cassava Sciences Inc - Threats
Cassava Sciences Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Cassava Sciences Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Nov 09, 2020: Cassava Sciences reports third quarter 2020 financial results
Aug 12, 2020: Cassava Sciences announces second quarter 2020 financial results and mid-year business review
Jun 18, 2020: Cassava Sciences: Departure of board of directors
May 06, 2020: Cassava Sciences reports first quarter 2020 financial results and provides business update
Mar 26, 2020: Cassava Sciences announces full-year 2019 financial results and anticipated key milestones for 2020
Mar 19, 2020: Cassava Sciences announces clinical update and business progress across Neuroscience pipeline
Oct 29, 2019: Cassava Sciences announces recent clinical highlights and third quarter 2019 financial results
Aug 12, 2019: Cassava Sciences announces second quarter 2019 financial results
Jun 18, 2019: Cassava Sciences to present at Maxim Groups Conference on Alzheimers Disease
May 28, 2019: Cassava Sciences announces new website launch
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Cassava Sciences Inc, Key Facts
Cassava Sciences Inc, Key Employees
Cassava Sciences Inc, Key Employee Biographies
Cassava Sciences Inc, Major Products and Services
Cassava Sciences Inc, History
Cassava Sciences Inc, Key Competitors
Cassava Sciences Inc, Ratios based on current share price
Cassava Sciences Inc, Annual Ratios
Cassava Sciences Inc, Interim Ratios
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Cassava Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Cassava Sciences Inc, Performance Chart (2015 - 2019)
Cassava Sciences Inc, Ratio Charts
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Interpace Biosciences Inc (IDXG) - Product Pipeline Analysis, 2020 Update

Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic

USD 750 View Report

Caris Life Sciences Inc - Product Pipeline Analysis, 2020 Update

Caris Life Sciences Inc (Caris Life) is a biotechnology company. The companys molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available